ClinicalTrials.Veeva

Menu

Quantitative Marrow Imaging, Marrow Reserve, And Clinical Outcomes In Patients Undergoing Radiotherapy For Hematologic And Related Disorders

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Hematologic
Bone Marrow

Treatments

Other: data collection

Study type

Observational

Funder types

Other

Identifiers

NCT07743476
NCI-2026-05811 (Other Identifier)
2026-0958

Details and patient eligibility

About

To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Undergoing or previously underwent radiotherapy at The University of Texas MD Anderson Cancer Center for hematologic or related disorders.
  • Available clinical, imaging, laboratory, treatment, and/or outcome data relevant to study objectives.
  • Ability to provide informed consent for prospective participation, when applicable.

Exclusion Criteria

Participants meeting any of the following criteria will be excluded:

  • Inability to provide informed consent, or when applicable, the absence of a legally authorized representative able to provide consent for prospective participation.
  • Insufficient clinical information available to support study objectives.
  • Pregnant women

Trial contacts and locations

1

Loading...

Central trial contact

Omran Saifi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems